GREB1L and gastric adenocarcinoma: In addition, a study confirmed that the methylation level of GREB1L is related to immune response and cytolysis in gastric adenocarcinoma, suggesting that it may be a new prediction and prognostic biomarker that aids in the therapy and predicts the overall survival possibility in patients with gastric adenocarcinoma11.